Fundación Renal Iñigo Alvarez de Toledo-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2015

  1. A labor and cost effective next generation sequencing of PKHD1 in autosomal recessive polycystic kidney disease patients

    Gene, Vol. 561, Núm. 1, pp. 165-169

  2. ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: A Next Generation Sequencing approach

    Clinical Chemistry and Laboratory Medicine, Vol. 53, Núm. 10, pp. 1515-1519

2014

  1. Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients

    Gene, Vol. 538, Núm. 1, pp. 195-198

2012

  1. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus

    Molecular Genetics and Metabolism, Vol. 105, Núm. 3, pp. 525-527

2011

  1. Erratum: Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes (Clinical Chemistry and Laboratory Medicine (2011) 49:5 (825-833))

    Clinical Chemistry and Laboratory Medicine

  2. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients

    Clinical Transplantation, Vol. 25, Núm. 3

  3. Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes

    Clinical Chemistry and Laboratory Medicine, Vol. 49, Núm. 5, pp. 825-833

  4. Pharmacogenetics of tacrolimus: Ready for clinical translation

    Kidney International Supplements, Vol. 1, Núm. 2, pp. 58-62